Pro-inflammatory signaling pathways and oxidative stress pathway

The 'Pro-inflammatory signaling pathways and oxidative stress pathway' refers to a broad and interconnected network of biological processes rather than a single molecular target. Pro-inflammatory pathways, such as the NF-κB, MAPK, and JAK-STAT cascades, regulate the production of cytokines and chemokines in response to cellular stress or infection, while oxidative stress pathways involve the balance between reactive oxygen species (ROS) production and antioxidant defenses like the Nrf2-Keap1 system (Source: NIH, PubMed). These pathways are critically linked; oxidative stress can trigger inflammatory responses through the activation of the inflammasome, and chronic inflammation can, in turn, induce further oxidative damage through the release of ROS by activated immune cells (Source: Nature Reviews Drug Discovery). Dysregulation of this axis is a primary driver in the pathogenesis of chronic conditions including rheumatoid arthritis, atherosclerosis, and neurodegenerative diseases like Alzheimer's (Source: StatPearls). Because this entry describes a collection of complex pathways rather than a specific protein, enzyme, or receptor, it is classified as a biological category rather than a discrete therapeutic target. Pharmacological intervention usually focuses on specific nodes within these pathways—such as TNF-alpha inhibitors or Nrf2 activators—to achieve therapeutic efficacy while minimizing systemic toxicity (Source: Wikipedia, PubMed).

Other names

Inflammation and oxidative stress pathwaysPro-inflammatory and redox signalingInflammatory-oxidative stress axisRedox-sensitive inflammatory signaling

Modulation of these pathways typically involves the inhibition of pro-inflammatory cytokines (e.g., TNF-alpha, IL-6), the blockade of intracellular signaling kinases (e.g., JAK, MAPK, IKK), or the activation of cytoprotective transcription factors like Nrf2 to enhance endogenous antioxidant defenses and neutralize reactive oxygen species (ROS).